| 摘要 |
The stem cell-augmenting material of the present invention being capable of augmenting stem cells consisting of somatic stem cells, particularly hematopoietic stem cells of bone marrow, and embryonic stem cells by being absorbed in vivo by oral ingestion, drops, etc. and capable of augmenting stem cells using isoflavone aglycone, which has estrogen-like activity and does not block the enzyme activity of enzymes that act on cell proliferation factor. There have been no stem cell-augmenting materials like the present invention whatsoever. The main characteristic of the present invention is that a stem cell-augmenting material that has the excellent activity is obtained because it has isoflavone aglycone that has a stem cell-augmenting activity.
|
